Cargando…
CA-125 monitoring in gynecologic cancer patients with COVID-19: A case series
CA-125 has long been utilized as a surveillance biomarker for gynecologic malignancies but can be elevated in other conditions, including infection. A study of tumor markers in non-cancer patients saw a rise in CA-125 values during severe COVID-19 infections. Given the potential confounding effect t...
Autores principales: | Folsom, Susan M., Mumford, Brigid, Lemon, Lara, Taylor, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212932/ https://www.ncbi.nlm.nih.gov/pubmed/35747786 http://dx.doi.org/10.1016/j.gore.2022.101029 |
Ejemplares similares
-
CA-125 monitoring in gynecologic cancer patients with COVID-19: A case series (413)
por: Mumford, Brigid, et al.
Publicado: (2022) -
Struma Ovarii Associated with Ascites and Elevated CA125: Two Case Reports and Review of the Literature
por: Wang, Shaoyu, et al.
Publicado: (2022) -
Obstructive oligo-anuria revealing pelvic gynecological cancers, analysis of a series of 102 cases
por: Kbirou, A., et al.
Publicado: (2022) -
Immune checkpoint inhibitors in liver transplant: a case series
por: Rudolph, Mark, et al.
Publicado: (2023) -
Nimotuzumab for COVID-19: case series
por: Abdo Cuza, Anselmo A, et al.
Publicado: (2021)